| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
119,920,000 |
| Market
Cap: |
2.49(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.96 - $32.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
97,298 |
194,789 |
253,657 |
527,733 |
| Total Sell Value |
$1,992,536 |
$3,809,170 |
$5,326,320 |
$13,514,934 |
| Total People Sold |
3 |
6 |
6 |
7 |
| Total Sell Transactions |
4 |
19 |
39 |
77 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ho Carole |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
AS |
$18.62 |
$86,711 |
D/D |
(4,617) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
OE |
$5.28 |
$24,378 |
D/D |
4,617 |
3,906 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-06-03 |
4 |
AS |
$19.07 |
$349,610 |
I/I |
(18,333) |
2,560,971 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-05-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
40,000 |
2,520,971 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-05-13 |
4 |
AS |
$21.09 |
$52,725 |
I/I |
(2,500) |
640,089 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-05-10 |
4 |
AS |
$22.19 |
$55,475 |
I/I |
(2,500) |
642,589 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.16 |
$73,483 |
I/I |
(3,316) |
103,806 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.17 |
$56,445 |
D/D |
(2,546) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
OE |
$5.28 |
$13,443 |
D/D |
2,546 |
2,546 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$57,150 |
I/I |
(2,500) |
645,089 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.83 |
$73,438 |
I/I |
(3,210) |
107,122 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$60,792 |
D/D |
(2,653) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
OE |
$5.28 |
$14,008 |
D/D |
2,653 |
2,653 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.51 |
$74,339 |
I/I |
(3,162) |
110,332 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.50 |
$61,406 |
D/D |
(2,613) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
OE |
$5.28 |
$13,797 |
D/D |
2,613 |
2,613 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-05-03 |
4 |
AS |
$24.49 |
$149,658 |
I/I |
(6,111) |
2,579,304 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-05-02 |
4 |
AS |
$24.03 |
$146,847 |
I/I |
(6,111) |
2,585,415 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-05-01 |
4 |
AS |
$24.09 |
$147,238 |
I/I |
(6,112) |
2,591,526 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-04-11 |
4 |
AS |
$27.73 |
$69,658 |
I/I |
(2,512) |
647,589 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-04-10 |
4 |
AS |
$28.26 |
$71,017 |
I/I |
(2,513) |
650,101 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-04-09 |
4 |
AS |
$28.17 |
$69,721 |
I/I |
(2,475) |
652,614 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-04-04 |
4 |
AS |
$26.24 |
$252,678 |
I/I |
(9,588) |
113,494 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-04-03 |
4 |
AS |
$26.29 |
$252,519 |
I/I |
(9,588) |
123,082 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-04-03 |
4 |
AS |
$26.27 |
$154,319 |
D/D |
(5,862) |
0 |
|
- |
|
416 Records found
|
|
Page 13 of 17 |
|
|
1.39 (6.28%) 
